Search

    Language Settings
    Select Website Language

    GDPR Compliance

    We use cookies to ensure you get the best experience on our website. By continuing to use our site, you accept our use of cookies, Privacy Policy, and Terms of Service.

    BijnorNews
    Bijnor news

    Aurobindo Pharma's Q1 Margin Story Improves; Macquarie Says Growth Picture Is Still Uneven

    13 hours ago

    Aurobindo Pharma reported a 25.2% year-on-year (YoY) rise in consolidated net profit to Rs 1,033 crore, while revenue increased 16.3% to Rs 9,150 crore.
    Click here to Read More
    Previous Article
    Double Hikes: Jefferies, Citi Raise Navin Fluorine's Target Price On Q1 Beat, New Capex Initiatives
    Next Article
    MV Electrosystems IPO Listing Live: Share Price, Listing Premium, GMP, NSE & BSE Debut Today

    Related Business Updates:

    Are you sure? You want to delete this comment..! Remove Cancel

    Comments (0)

      Leave a comment